The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trop-2 expression and its prognostic impact on endometrial cancer: A real-world data analysis.
 
Yi Zhang
Employment - Gilead Sciences
Stock and Other Ownership Interests - Allogene Therapeutics; Gilead Sciences
Patents, Royalties, Other Intellectual Property - DLL3 targeting chimeric antigen receptors and binding agents (Inst); Patent title - CHIMERIC SWITCH RECEPTORS FOR THE CONVERSION OF IMMUNESUPPRESSIVE SIGNALS TO COSTIMULATORY SIGNALS (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Gilead Sciences; Gilead Sciences
 
Linda Su-Feher
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Kaiwen Lin
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Simonetta Mocci
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Kimberly Komatsubara
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Shahed Iqbal
Employment - Gilead Sciences
Honoraria - Gilead Sciences
 
Jared Odegard
Employment - Gilead Sciences
Leadership - Abata Therapeutics (I); Dovetail Therapeutics (I); Odyssey Therapeutics (I)
Stock and Other Ownership Interests - ARS Pharmaceuticals (I)